Acerca de
Mr. MacMillan was named President and CEO of Hologic, the global leader in Women’s Health, in December 2013 and appointed Chairman in June 2015. He also serves as the Chairman of the Board of Illumina (the global leader in next-generation sequencing). He was Chairman, President and Chief Executive Officer of Stryker Corporation until February 2012. Mr. MacMillan began his career with Procter & Gamble in 1985 and later spent 11 years with Johnson & Johnson in both the U.S. and Europe and became President of the joint venture between Johnson & Johnson and Merck. In 2000, he joined Pharmacia Corporation’s Executive Committee where he oversaw five global businesses with revenues exceeding $2 billion. Mr. MacMillan was one of a small group of Fortune 500 CEO’s appointed to serve on the Department of Commerce’s Advanced Manufacturing Partnership to help the country rebound from the 08/09 downturn. He received a Bachelor of Arts degree in Economics from Davidson College and is a graduate of Harvard Business School’s Advanced Management Program.